Halozyme Therapeutics (HALO) EBT Margin Growth (3y) (2013 - 2026)
Halozyme Therapeutics (HALO) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Halozyme Therapeutics | 9.55 Bn | 9.23 Bn | 297.47 Mn | 1,565.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,565.00 |
| Dec 31, 2025 | -6,133.00 |
| Sep 30, 2025 | 2,654.00 |
| Jun 30, 2025 | 4,322.00 |
| Mar 31, 2025 | -914.00 |
| Dec 31, 2024 | 607.00 |
| Sep 30, 2024 | -705.00 |
| Jun 30, 2024 | -1,617.00 |
| Mar 31, 2024 | 1,747.00 |
| Dec 31, 2023 | -1,621.00 |
| Sep 30, 2023 | -843.00 |
| Jun 30, 2023 | -471.00 |
| Mar 31, 2023 | 5,625.00 |
| Dec 31, 2022 | 10,322.00 |
| Sep 30, 2022 | 8,935.00 |
| Jun 30, 2022 | 5,701.00 |
| Mar 31, 2022 | 6,025.00 |
| Dec 31, 2021 | 5,674.00 |
| Sep 30, 2021 | 17,295.00 |
| Jun 30, 2021 | 13,201.00 |